Duraphat® 5,000ppm fluoride toothpaste is licensed for the prevention of dental caries in adolescents and adults, particularly amongst patients at risk from multiple caries (coronal and/or root caries).
|NCPE Assessment Process||Completed|
|Rapid review commissioned||30/07/2019|
|Rapid review completed||06/01/2020|
|Rapid Review outcome||A full HTA is not recommended. The NCPE recommends that Duraphat® 5,000 ppm Fluoride toothpaste not be considered for reimbursement on the Community Drug Schemes. The NCPE recommend that Duraphat® 5000 ppm Fluoride toothpaste be reimbursed on an individual patient basis*.|
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.